The Cost-Effectiveness of Compounding Pharmacies - Episode 348

From Gladden Longevity Podcast -- formerly Living Beyond 120 Gladden Longevity Podcast

In this episode of the Gladden Longevity podcast, Dr. Gladden interviews Shaun Noorian from Empower Pharmacy, discussing the growth and mission of the pharmacy, the cost-effectiveness of compounding medications, quality standards in compounding, regulatory oversight, and the ongoing controversy surrounding peptides and FDA decisions. The conversation highlights the importance of personalized medicine and the challenges faced by compounding pharmacies in providing affordable and effective treatments for patients. In this conversation, Dr. Gladden and Shaun Noorian discuss the evolving landscape of compounding pharmacies and personalized medicine. They explore the regulatory challenges faced by compounding pharmacies, the promise of new medications like retatrutide, and the role of GLP-1s in health management. The discussion highlights the importance of muscle preservation in weight loss therapies and the advocacy needed to ensure patient access to compounded medications. They emphasize the renaissance of compounding in healthcare, which is making treatments more accessible and affordable for patients.

For Audience

Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!

Takeaways

· Empower Pharmacy has been operational for 17 years and focuses on personalized medicine.

· Compounding pharmacies are becoming more popular due to their cost-effectiveness compared to commercial options.

· Quality standards in compounding are well-established and continuously updated.

· Compounding pharmacies are subject to rigorous regulatory oversight and inspections.

· The FDA is currently reviewing the status of several peptides for compounding.

· Recent changes in the FDA advisory committee may impact the approval of new compounds.

· The conversation emphasizes the need for evidence-based decisions in healthcare.

· Dr. Gladden highlights the discrepancies in drug approvals and their implications for patient care.

· The black market for peptides poses significant risks to patient safety.

· The discussion underscores the importance of maintaining high-quality standards in compounding pharmacies. The FDA's decisions will significantly impact compounding pharmacies.

· Compounding pharmacies ensure medication integrity and safety.

· Personalized medicine is expanding into various health areas.

· Regulatory challenges hinder the compounding of certain medications.

· Retatrutide is expected to revolutionize weight loss therapies.

· GLP-1s have multiple health benefits beyond weight loss.

· Weight loss therapies can lead to muscle loss, complicating health outcomes.

· Innovative alternatives to GLP-1s are emerging in the market.

· Compounding pharmacies play a crucial role in patient access to medications.

· Advocacy against pharmaceutical monopolies is essential for patient care.

Chapters

00:00 Empower Pharmacy's Growth and Mission

03:01 Cost-Effectiveness of Compounding Pharmacies